Next Article in Journal
Acceptance of Nirsevimab for the Prevention of Respiratory Syncytial Virus Infection in Neonates: A Cross-Sectional Survey in Emilia-Romagna, Italy
Next Article in Special Issue
Post-Polio Syndrome: Impact of Humoral Immune Deficiencies, Poliovirus Neutralizing Antibodies, Vitamin D Deficiency
Previous Article in Journal
Review of Human Papillomavirus Vaccination Programs in United States Schools
Previous Article in Special Issue
A Phase II Random, Double-Blind, Placebo-Controlled Study of the Safety and Immunogenicity of a Recombinant G Protein-Based Respiratory Syncytial Virus Vaccine in Healthy Older Adults
 
 
Review

Article Versions Notes

Vaccines 2025, 13(9), 895; https://doi.org/10.3390/vaccines13090895
Action Date Notes Link
article xml file uploaded 23 August 2025 06:42 CEST Original file -
article xml uploaded. 23 August 2025 06:42 CEST Update -
article pdf uploaded. 23 August 2025 06:42 CEST Version of Record https://www.mdpi.com/2076-393X/13/9/895/pdf-vor
article html file updated 23 August 2025 06:45 CEST Original file -
article xml file uploaded 26 August 2025 08:33 CEST Update -
article xml uploaded. 26 August 2025 08:33 CEST Update https://www.mdpi.com/2076-393X/13/9/895/xml
article pdf uploaded. 26 August 2025 08:33 CEST Updated version of record https://www.mdpi.com/2076-393X/13/9/895/pdf
article html file updated 26 August 2025 08:36 CEST Update https://www.mdpi.com/2076-393X/13/9/895/html
Back to TopTop